Nevada Jury Orders Drug Firms to Pay $162M in Hepatitis C Case
A Nevada jury is ordering pharmaceutical companies to pay $162.5 million in punitive damages in a lawsuit stemming from a Las Vegas hepatitis C outbreak in 2008.
The damages awarded Monday in Clark County District Court are on top of the $20.1 million in compensatory damages awarded to five plaintiffs Thursday after a jury found Teva Parenteral Medicines Inc., Baxter Healthcare Corp. and McKesson Corp. liable after a seven-week trial.
Plaintiffs’ lawyers had been seeking $600 million in punitive damages.
At least one of the drug companies is planning an immediate appeal.
Plaintiffs accused the drug companies of distributing dangerously large vials of the powerful anesthetic propofol to clinics where doctors and anesthesiologists are suspected of reusing vials – despite warnings that the practice could spread blood-borne diseases.
- Warren, Hawley Press Insurers Over Closed, Unpaid Claims
- First Atlantic Hurricane of 2026 to Threaten US Gulf Coast
- HSBC Executive Strikes Back in Court Fight Over Poaching Claims
- Goldman Sachs Ensnared in EY Data Breach Earlier This Year
- Are We Training Claims Adjusters or Claims Processors?
- The Nation’s Insurance Laboratory: What Liability Trends in California Mean for the Rest of the Country
- The Great Hemp Reset: How the Federal Ban on Intoxicating Hemp Products Will Reshape Risk and Coverage
- Credit Acceptance Reaches $710M Predatory Auto Lending Settlement With Most States